NRF2 Induction for NASH Treatment: A New Hope Rises
Cell Mol Gastroenterol Hepatol
.
2018 Jan 10;5(3):422-423.
doi: 10.1016/j.jcmgh.2017.12.009.
eCollection 2018 Mar.
Authors
Montserrat Rojo de la Vega
1
1
2
,
Donna D Zhang
1
2
Affiliations
1
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.
2
Arizona Cancer Center, University of Arizona, Tucson, Arizona.
PMID:
29675456
PMCID:
PMC5904030
DOI:
10.1016/j.jcmgh.2017.12.009
No abstract available
Publication types
Editorial
Grants and funding
P30 CA023074/CA/NCI NIH HHS/United States
R01 ES023758/ES/NIEHS NIH HHS/United States
P30 ES006694/ES/NIEHS NIH HHS/United States
R01 DK109555/DK/NIDDK NIH HHS/United States
R01 ES026845/ES/NIEHS NIH HHS/United States